XYNVIVO Trademark

Trademark Overview

On Friday, September 8, 2023, a trademark application was filed for XYNVIVO with the United States Patent and Trademark Office. The USPTO has given the XYNVIVO trademark a serial number of 98170489. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 25, 2025. This trademark is owned by Lupagen, Inc.. The XYNVIVO trademark is filed in the Medical Instrument Products category with the following description:

medical device for producing and delivering cell therapy to a patient, namely, infusion and injection devices for administering drugs
xynvivo

General Information

Serial Number98170489
Word MarkXYNVIVO
Filing DateFriday, September 8, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements

Goods and Servicesmedical device for producing and delivering cell therapy to a patient, namely, infusion and injection devices for administering drugs

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 29, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLupagen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrving, TX 75063
Party NameLupagen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063

Trademark Events

Event DateEvent Description
Friday, September 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023NEW APPLICATION ENTERED
Friday, May 3, 2024ASSIGNED TO EXAMINER
Friday, May 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 21, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, July 1, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, July 1, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 1, 2024EXAMINERS AMENDMENT E-MAILED
Monday, July 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 1, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, July 1, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 25, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, February 13, 2025EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, September 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 12, 2025TEAS STATEMENT OF USE RECEIVED

Related Keywords

xynvivo injection infusion devices administering drugs namely patient producing device delivering